Possible Mechanisms of the Interplay between Drugs and Mycotoxins—Is There a Possible Impact? by Orphélie Lootens, An Vermeulen, Siska Croubels, Sarah De Saeger, Jan Van Bocxlaer, Marthe De Boevre

Get full text

Exploring the Impact of Efavirenz on Aflatoxin B1 Metabolism: Insights from a Physiologically Based Pharmacokinetic Model and a Human Liver Microsome Study by Orphélie Lootens, Marthe De Boevre, Elke Gasthuys, Sarah De Saeger, Jan Van Bocxlaer, An Vermeulen

Get full text

Building a Human Physiologically Based Pharmacokinetic Model for Aflatoxin B1 to Simulate Interactions with Drugs by Orphélie Lootens, Marthe De Boevre, Jia Ning, Elke Gasthuys, Jan Van Bocxlaer, Sarah De Saeger, An Vermeulen

Get full text

Altered intravenous drug disposition in people living with cystic fibrosis: A meta‐analysis integrating top‐down and bottom‐up data by Pieter‐Jan De Sutter, Maxime Van Haeverbeke, Eva Van Braeckel, Stephanie Van Biervliet, Jan Van Bocxlaer, An Vermeulen, Elke Gasthuys

Get full text

Unravelling the pharmacokinetics of aflatoxin B1: In vitro determination of Michaelis–Menten constants, intrinsic clearance and the metabolic contribution of CYP1A2 and CYP3A4 in p... by Orphélie Lootens, Orphélie Lootens, Orphélie Lootens, Marthe De Boevre, Marthe De Boevre, Elke Gasthuys, Jan Van Bocxlaer, An Vermeulen, Sarah De Saeger, Sarah De Saeger, Sarah De Saeger

Get full text

Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma by Elien De Thaye, Koen Van de Vijver, Joni Van der Meulen, Joachim Taminau, Glenn Wagemans, Hannelore Denys, Jo Van Dorpe, Geert Berx, Wim Ceelen, Jan Van Bocxlaer, Olivier De Wever

Get full text